Registration is now open!
Registration includes 3 days of educational and focus group sessions, PLUS all meals, receptions and dinners!
CTTACC 2025
MARK YOUR CALENDAR
MAY 4-7, 2025 | SCOTTSDALE, AZ
MAY 4-7, 2025 | SCOTTSDALE, AZ
Omni Scottsdale Resort & Spa at Montelucia
Poster session / Abstract Submission - Open Now - Deadline to Submit is March 14, 2025
We are looking for poster presentations in the topic areas of:
Cellular and regenerative therapies in trauma and critical care medicine.
Transfusion medicine and novel products or devices for critically injured patients.
Fundamental scientific presentations in thewe topic areas are also encouraged.
Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies
Co-hosted by Colorado State University and the Armed Forces Institute of Regenerative Medicine
This is the sixth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine” It is our belief that cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross-disciplinary collaborations and grants for pre-clinical studies and clinical trials.
Our mission is highly focused on supporting the development and translation of novel therapies in trauma and critical care medicine. The goal of our meeting is to bring together the expertise and input of blood bankers, cell therapy producers, clinicians, basic scientists, industry, FDA, AFIRM, MTEC, NIH, AABB, DARPA, BARDA and DOD representatives to discuss current research and existing barriers in the translation of these novel therapies in trauma and critical care medicine, a field with limited therapeutic options and unlimited opportunities for advancement.
CTTACC 2025 Sessions
- Key Topics in Trauma and Transfusion Medicine
- Military health session focused on battlefield medicine and pre-Role 2 care of wounded warfighters, including prolonged casualty care, novel blood products, point-of-care devices, neurotrauma, and regenerative cell therapy approaches.
- Technological Integration and Innovation in Gene Editing and Therapy Outside of Oncological Applications:
- Cellular Therapies and Transfusion Medicine in Chronic Critical Illness (Immunomodulation, Chronic Critical Illness, Cardiac Repair and Regeneration, SCI, TBI, Spina Bifida)
- Cellular Therapies and Transfusion Medicine in Acute Trauma and Critical Illness (ARDS, AKI, Cardiac Repair and Regeneration)
- Regenerative Approaches and Blood Transfusion in Burns, TBI and Sepsis
- Novel Blood Products: Dried and Stem Cell-Derived Blood Products
- Blood Products and Stem Cells as a Discovery Platform for Novel Regenerative Factors
- FDA Regulatory Panel: Ethical, Legal and Regulatory Challenges for Novel Products and Technology
- Funding Agency Stakeholders Panel
- Focus group 1: Next-Generation Solutions for Wound Healing and Tissue Regeneration
- Focus Group 2: From Battlefield to Bedside: Overcoming Challenges in Developing a Dried Plasma Product for Military and Civilian Use
CTTACC is hosting a poster session
Abstract submission is open now. Submission Deadline: March 14, 2025
Cellular Therapies Topics
Spinal Cord Injury (SCI)
Traumatic Brain Injury (TBI)
Hemorrhagic Shock
Wound Healing
Orthopedic Injury
Organ Failure
Acute Respiratory Distress Syndrome (ARDS)
Acute Kidney Injury (AKI)
Cell Processing and Product Development
Cardiovascular Disease
Novel Blood Product and Transfusion Topics
Whole Blood Transfusion
Hemorrhage Control
Adjunct to Resuscitation
Stem Cell Derived Blood Products
Dried Plasma and Platelets
Cold Stored Platelets
Platelet Extracellular Vesicles
SIGNUP FOR MORE INFORMATION
Questions? Email us at [email protected] or call 303-238-0685